Founders Capital Management Volitionrx LTD Transaction History
Founders Capital Management
- $154 Million
- Q2 2024
A detailed history of Founders Capital Management transactions in Volitionrx LTD stock. As of the latest transaction made, Founders Capital Management holds 2,000 shares of VNRX stock, worth $1,160. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$1,160
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VNRX
# of Institutions
31Shares Held
8.17MCall Options Held
53.6KPut Options Held
300-
Lagoda Investment Management, L.P. New York, NY5.44MShares$3.15 Million1.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$369,2660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA635KShares$368,0370.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$299,3220.0% of portfolio
-
Cowen Prime Advisors LLC179KShares$103,6680.09% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $33.2M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...